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Triiodothyronine (T3) stimulates a robust increase
(>40-fold) in transcription of the malic enzyme gene in
chick embryo hepatocytes. Previous work has shown that
optimal T3 regulation of malic enzyme transcription is
dependent on the presence of an accessory element (des-
ignated as region E) that immediately flanks a cluster of
five T3 response elements in the malic enzyme gene. Here,
we have analyzed the binding of nuclear proteins to re-
gion E and investigated the mechanism by which region E
enhances T3 responsiveness. In nuclear extracts from
hepatocytes, region E binds heterodimeric complexes
consisting of the homeodomain proteins PBX and MEIS1.
Region E contains four consecutive PBX/MEIS1 half-sites.
PBX-MEIS1 heterodimers bind the first and second half-
sites, the third and fourth half-sites, and the first and
fourth half-sites. The configuration conferring the great-
est increase in T3 responsiveness consists of the first and
fourth half-sites that are separated by 7 nucleotides. Stim-
ulation of T3 response element functions by region E does
not require the presence of additional malic enzyme se-
quences. In pull-down experiments, PBX1a and PBX1b
specifically bind the nuclear T3 receptor-a, and this inter-
action is enhanced by the presence of T3. A T3 receptor-a
region containing the DNA binding domain plus flanking
sequences (amino acids 21–157) is necessary and sufficient
for binding to PBX1a and PBX1b. These results indicate
that PBX-MEIS1 complexes interact with nuclear T3
receptors to enhance T3 regulation of malic enzyme
transcription in hepatocytes.
Malic enzyme catalyzes the oxidative decarboxylation of
malate to pyruvate and CO2, simultaneously generating
NADPH from NADP1. This reaction is the primary source of
reducing equivalents for de novo synthesis of long chain fatty
acids in avian liver (1). Regulation of malic enzyme activity is
typical of that of other lipogenic enzymes. Malic enzyme activ-
ity increases by 70-fold when previously starved chicks are fed
a high carbohydrate, low fat diet and dramatically decreases
when animals are starved (2). Nutritional regulation of malic
enzyme activity is quantitatively mimicked in primary cultures
of chick embryo hepatocytes by manipulating the concentra-
tions of hormones and metabolic fuels in the culture medium.
Insulin, glucose, and 3,5,39-triiodothyronine (T3),1 humoral fac-
tors that are elevated during consumption of a high carbohy-
drate, low fat diet, increase malic enzyme activity in chick
embryo hepatocytes (3, 4). T3 alone stimulates malic enzyme
activity; insulin and glucose amplify the action of T3 but have
little effect when added by themselves. Glucagon and fatty
acids, humoral factors that are elevated during starvation,
inhibit the stimulation of malic enzyme activity caused by T3
(3, 5). Alterations in malic enzyme activity caused by nutri-
tional manipulation in vivo and nutrients and hormones in
culture are mediated primarily by changes in the rate of tran-
scription of the malic enzyme gene (4–7).
In addition to regulation by nutrients and hormones, malic
enzyme transcription is controlled in a tissue-specific or cell
type-specific manner. In chicks fed a high carbohydrate, low fat
diet, malic enzyme transcription is high in liver and low in
heart, kidney, and brain (6). Nutritional manipulation has no
effect on malic enzyme transcription in heart, kidney, and
brain. Cell type-dependent differences in the regulation of
malic enzyme are also observed in cells in culture. T3 stimu-
lates a 40-fold or greater increase in malic enzyme transcrip-
tion in chick embryo hepatocytes, whereas in chick embryo
fibroblasts and quail QT6 cells, T3 has little or no effect on
malic enzyme transcription (8).
The robust effects of T3 on malic enzyme transcription in
chick embryo hepatocytes makes this an excellent system to
study the molecular mechanisms by which T3 regulates tran-
scription. T3 activates gene transcription by interacting with
nuclear T3 receptors (TR) (9, 10). TRs bind T3 response ele-
ments (T3RE) of target genes as homodimers or heterodimers
with the retinoid X receptor (RXR). T3REs consist of multiple
copies of a hexameric sequence related to a consensus RGG-
WMA arranged as inverted repeats, everted repeats, direct
repeats, or as extended single copies of the hexamer (11). The
T3-induced increase in malic enzyme transcription in chick
embryo hepatocytes is mediated by at least six T3REs (12–14).
One strongly active and four weakly active T3REs are clustered
in a 109-bp region located at 23878/23769 bp relative to the
transcription start site. This cluster of T3REs is referred to as
a T3 response unit (T3RU). Another weakly active T3RE is
located about 700 bp downstream of the T3RU. All of the malic
enzyme T3REs consist of directly repeated hexameric half-sites
separated by a 4-bp spacer and bind TR-RXR heterodimers in
hepatic nuclear extracts.
In addition to T3REs, accessory elements that bind nonre-
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ceptor proteins play an important role in mediating the effects
of T3 on malic enzyme transcription. We have identified four
accessory elements in the malic enzyme gene that confer dif-
ferences in T3 regulation of malic enzyme transcription be-
tween chick embryo hepatocytes and chick embryo fibroblasts
(15). Each element enhances T3 responsiveness of the malic
enzyme promoter in chick embryo hepatocytes but has no effect
on T3 responsiveness in chick embryo fibroblasts. Three of the
accessory elements immediately flank the T3RU and are des-
ignated regions A, E, and F. The T3RU and accessory elements
A, E, and F overlap with a hepatocyte-specific and T3-inducible
region of DNase I hypersensitivity in chromatin. Region F
(23703/23686 bp) binds the liver-enriched factor, CCAAT/en-
hancer-binding protein-a (C/EBPa). The identities of the pro-
teins that bind region A (23895/23890 bp) and region E
(23761/23744 bp) have not yet been determined. The nature of
the proteins that bind region E is of particular interest because
mutation of this element causes the largest decrease in T3-
induced malic enzyme transcription of the four accessory ele-
ments identified.
PBX proteins are members of the 3-amino acid loop exten-
sion superclass of homeodomain proteins (16). The pbx1 gene
was first identified as a site of t(1,19) chromosomal transloca-
tion leading to the production of an E2a-PBX1 fusion protein in
a subset of pre-B cell acute lymphoblastic leukemias in humans
(17, 18). Highly conserved homologs of PBX have been identi-
fied in Drosophila melanogaster (19), Caenorhabditis elegans
(16), and zebrafish (20). Genetic and biochemical analyses have
shown that PBX proteins regulate developmental pathways by
serving as cofactors for other homeodomain transcription fac-
tors. For example, PBX potentiates the effects of HOX proteins
on segmentation along the anterior-posterior axis (21). This
effect is mediated by heterodimeric interactions between PBX
and HOX. PBX-HOX complexes bind DNA with enhanced spec-
ificity and affinity compared with complexes containing PBX or
HOX alone (22–24). PBX also binds cooperatively to DNA with
other 3-amino acid loop extension class homeodomain proteins
including MEIS1 and the closely related factor, PREP1 (also
referred to as pKnox) (25–28). Complexes containing PBX-
MEIS1 or PBX-PREP1 are components of the transcriptional
network controlling cell fate and segmental patterning during
embryonic development (29–31).
Recent studies have shown that PBX, MEIS1, and PREP1
also function in maintaining cellular differentiation in adult
tissues. For example, PBX-PREP1 heterodimers mediate the
pancreatic-specific transcription of the genes for somatostatin
and glucagon (32, 33). In the case of the somatostatin gene,
PBX-PREP1 stimulates transcription in pancreatic cells by
potentiating the transcriptional activity of the pancreatic-
specific homeodomain factor, PDX1 (32). In the case of the
glucagon gene, PBX-PREP1 binds to a cis-acting element that
represses glucagon transcription in non-pancreatic cells with-
out affecting glucagon transcription in pancreatic cells (33).
Other work (34) has shown that a PBX-MEIS-PDX1 trimeric
complex activates transcription of the elastase I gene in pan-
creatic acinar cells via interactions with the acinar cell-specific
factor, PTF1. Still other studies have shown that PBX-PREP1
heterodimers interact with a cis-acting element that confers
cell type-specific transcription of the human a2(V) collagen
gene (35). In addition to the pancreas and tissues that express
a2(V) collagen, PBX and MEIS1/PREP1 proteins are expressed
at significant levels in other adult tissues, including liver (36–
40). The physiological role of these proteins in liver has not
been established.
In the present study, we have analyzed the binding of nu-
clear proteins to malic enzyme region E in hepatocytes. We
show that this TR accessory element binds PBX-MEIS1 het-
erodimers in multiple configurations. In addition, we have de-
veloped data suggesting that the stimulation of T3-induced
malic enzyme transcription by region E is mediated by direct
interactions between PBX and TR.
EXPERIMENTAL PROCEDURES
Plasmids—The DNA fragments used to construct reporter plasmids
were named by designating the 59 and 39 ends of each fragment relative
to the start site of transcription of the malic enzyme gene. p[ME23921/
23631]ME2147/131CAT has been described previously (15). This re-
porter plasmid contains the malic enzyme T3RU and flanking se-
quences (23921 to 23631 bp) linked to the minimal promoter of the
malic enzyme gene (2147 to 131 bp). Site-directed mutations were
introduced into p[ME23921/23631]ME2147/131CAT using a polym-
erase chain reaction-based strategy (41). p[T3RE-2]ME2147/131CAT
was made by subcloning the major malic enzyme T3RE between 23883
and 23858 bp into the BamHI/SacI site upstream of the minimal
promoter in ME2147/131CAT. p[T3RE-21Region E]ME2147/
131CAT was constructed by inserting region E (ME23767/23742) into
the SpeI/SmaI site immediately downstream of the of T3RE-2 in
p[T3RE-2]ME2147/131CAT. Dr. M. Kamps (University of California,
San Diego) provided the cDNAs for human PBX1a and PBX1b. The
cDNA for mouse MEIS1 was obtained by Dr. N. Copeland (NCI-Fred-
erick Cancer Research and Development Center). Drs. H. Chen and S.
Antonarakis (University of Geneva) supplied the cDNA for human
PREP1. cDNAs for full-length PBX1a (PBX1a-(1–430)), PBX1b
(PBX1b-(1–347)), MEIS1 (MEIS1-(1–390)), and PREP1 (PREP1-(1–
436)) and human RXRa (RXRa-(1–462)) were subcloned into pSV-
SPORT1 (Life Technologies, Inc.). Expression plasmids containing N-
terminal truncations of PBX1a (PBX1a-(80–430) and PBX1a-(119–
430)) were provided by Dr. C. Murre (University of California, San
Diego). The full-length cDNA of chicken TRa corresponding to amino
acids 1–408 (TRa-(1–408)) was subcloned into pGEM-3Zf(2) (Pro-
mega). N-terminal and C-terminal deletion derivatives of chicken TRa
were generated by polymerase chain reaction. Polymerase chain reac-
tion products encoding TRa polypeptides containing amino acids 1–118,
1–157, 21–408, 51–408, and 120–408 were subcloned into pGEM-
3Zf(2). To generate plasmids that express fusion proteins containing
glutathione S-transferase (GST) linked to PBX1a, PBX1b, or TRa,
cDNAs containing the full-length coding region of PBX1a, PBX1b, or
TRa were subcloned into pGEX-2T (Amersham Pharmacia Biotech).
Structures of reporter plasmids and expression plasmids were con-
firmed by restriction enzyme mapping and nucleotide sequence
analyses.
Cell Culture and Transient Transfection—Primary cultures of chick
embryo hepatocytes were prepared as described previously (42) and
maintained in serum-free Waymouth medium MD705/1 containing 50
nM insulin (gift from Lilly) and corticosterone (1 mM). Hepatocytes were
incubated at 40 °C in a humidified atmosphere of 5% CO2 and 95% air.
Cells were transfected using a modification of the method of Baillie et
al. (43). Briefly, chick embryo hepatocytes were isolated as described
above and plated on 35-mm dishes. At 18 h of incubation, the medium
was replaced with one containing 20 mg of LipofectACE (Life Technol-
ogies, Inc.), 3.0 mg of p[ME23921/23631]ME2147/131CAT, or an
equimolar amount of another reporter plasmid and 0.05 mg of pCMV-
b-galactosidase. At 42 h of incubation, the transfection medium was
replaced with fresh medium with or without T3 (1.5 mM). At 90 h of
incubation, chick embryo hepatocytes were harvested, and cell extracts
were prepared for CAT (44) and b-galactosidase (45) measurements.
CAT activity was expressed relative to b-galactosidase activity to cor-
rect for differences in transfection efficiency between samples. All
DNAs used in transfection experiments were purified using the Qiagen
endotoxin-free kit.
Gel Mobility Shift Analysis—Nuclear extracts were prepared from
chick embryo hepatocytes incubated with or without T3 for 24 h. Nuclei
and nuclear extracts were prepared as described (46) except that the
protease inhibitors leupeptin (0.25 mg/ml), benzamidine (10 mM), and
PMSF (0.5 mM) were added to the extraction and dialysis buffers at the
indicated concentrations. PBX1a, PBX1b, MEIS1, PREP1, RXRa, and
TRa were translated in vitro using the TNT SP6-coupled reticulocyte
lysate system (Promega). Incorporation of [35S]methionine into PBX1a,
PBX1b, MEIS1, PREP1, RXRa, and TRa was measured in parallel
reactions in order to assess the relative efficiency of synthesis of the
different transcription factors.
Double-stranded oligonucleotides were prepared by combining equal
amounts of the complementary single-stranded DNA in a solution con-
Regulation of Malic Enzyme Transcription by PBX and MEIS1 23839
taining 10 mM Tris, pH 8.0, 1 mM EDTA followed by heating to 95 °C for
2 min and then cooling to room temperature. The annealed oligonucleo-
tides were labeled by filling in overhanging 59 ends using the Klenow
fragment of Escherichia coli DNA polymerase in the presence of
[a-32P]dCTP. Binding reactions were carried out in 20 ml containing 18
mM HEPES, pH 7.9, 90 mM KCl, 0.18 mM EDTA, 0.45 mM dithiothreitol,
18% glycerol (v/v), 0.3 mg/ml bovine serum albumin, and 2 mg of poly(dI-
dC). A typical reaction contained 20,000 cpm of labeled DNA and 10 mg
of nuclear extract or 2 mg of in vitro translated proteins. The reaction
was carried out on ice for 60 min. DNA and DNA-protein complexes
were resolved on 6% nondenaturing polyacrylamide gels at 4 °C in 0.53
TBE (45 mM Tris, pH 8.3, 45 mM boric acid, 1 mM EDTA). Following
electrophoresis, the gels were dried and subject to storage phosphor
autoradiography. For competition experiments, unlabeled competitor
DNA was mixed with radiolabeled oligomer prior to addition of nuclear
extract. For gel supershift experiments, nuclear extracts or in vitro
translated proteins were incubated with antibodies for 1 h at 0 °C prior
to addition of the oligonucleotide probe. An antiserum that reacts with
all isoforms of PBX (PBX1, -2, and -3) (47) was generously provided by
Dr. M. Kamps (University of California, San Diego). A polyclonal anti-
body that reacts with MEIS1 and PREP1 (sc-6245) was purchased from
Santa Cruz Biotechnology. Synthetic oligonucleotides that were used as
probes or competitors in gel mobility shift assays are listed in Fig. 3.
Protein-Protein Interactions—GST or GST fusion proteins were ex-
pressed in E. coli (BL21, pLysS) and purified using standard techniques
(48). Briefly, bacteria were transformed with pGEX-2T or recombinant
pGEX-2T plasmids expressing GST fusion proteins. Overnight bacterial
cultures in ampicillin (250 mg/ml) were diluted 1:100 into 250 ml of
Luria broth and grown at 37 °C to an A600 5 1.0 before induction with
1 mM isopropylthiogalactopyranoside for 60 min. Cells were pelleted
and resuspended in 5 ml of buffer A (50 mM KCl, 25 mM HEPES, pH 7.9,
6% glycerol, 5 mM EDTA, 5 mM MgCl2, 1 mM dithiothreitol, 0.05%
Triton X-100). Cells were lysed on ice by sonication and centrifuged at
12,000 3 g for 10 min at 4 °C. The supernatant was mixed for 1 h at 4 °C
on a rotator with 0.5–1 ml of 50% glutathione-Sepharose beads (Amer-
sham Pharmacia Biotech) that were preswollen in buffer A. After ab-
sorption, beads were collected by centrifugation at 4 °C and washed
three times with 1 ml of buffer A. Fusion proteins coupled to the
glutathione-Sepharose beads were stored at 4 °C as 50% (v/v) slurry in
buffer A. The concentrations and sizes of GST and GST fusion proteins
were estimated by SDS-PAGE, using a known quantity of molecular
weight standards.
L-[35S]Cysteine- or L-[35S]methionine-labeled proteins were prepared
by using TNT reticulocyte lysates (Promega). Approximately 2.5 3 104
to 5 3 104 cpm of 35S-labeled protein were incubated with 100 ng of GST
fusion protein immobilized on glutathione-Sepharose beads in 300 ml of
buffer A for 1 h at 4 °C on a rotator. Beads were collected by centrifu-
gation at 4 °C and washed three times with 1 ml of buffer A. The bound
proteins were eluted with SDS-gel loading buffer and analyzed by
SDS-PAGE followed by storage phosphor autoradiography. Where in-
dicated 1 mM T3 or 9-cis-retinoic acid was included in the binding
reaction mixture. 35S-Labeled proteins were analyzed by electrophore-
sis and storage phosphor autoradiography to ensure that similar levels
of input radioactivity of the labeled protein were used in the GST
binding assays.
RESULTS
PBX/MEIS1 Heterodimers Bind Region E of the Malic En-
zyme Gene—Previous work (25–28) has shown that PBX binds
DNA as heterodimers with other homeodomain factors such as
MEIS1 and PREP1 in terminally differentiated cells. PBX,
MEIS1, and PREP1 interact with 4-bp sequence elements re-
ferred to as half-sites. Selection studies with degenerate oligo-
nucleotides have shown that PBX-MEIS1 and PBX-PREP1
heterodimers bind two contiguous half-sites with the consensus
sequence, 59-TGAT-TGAC-39, in which PBX contacts the up-
stream half-site and MEIS1/PREP1 contacts the downstream
half-site (Fig. 1A) (27, 47). This sequence is referred to as the
FIG. 1. Characterization of proteins
that bind to region E using the gel mo-
bility shift assay. A, comparison of the
sequence of malic enzyme region E with
the PBX cooperativity sequence (PCE). The
four potential tetrameric half-sites are
overlined. B, gel mobility shift experiments
were performed using nuclear extracts pre-
pared from chick embryo hepatocytes
(CEH). A double-stranded DNA fragment
containing region E (23767 to 23742 bp)
was labeled with [a-32P]dCTP using the
Klenow fragment of E. coli DNA polymer-
ase. The radiolabeled probe was incubated
with nuclear extract as described under
“Experimental Procedures.” DNA and
DNA-protein complexes were resolved on
6% nondenaturing polyacrylamide gels.
Nuclear extracts were incubated with an-
tibodies against PBX and MEIS1/PREP1
prior to the addition of the probe. Positions
of the specific DNA-protein complexes and
supershifted complexes are indicated by
arrows. These data are representative of
three different experiments employing in-
dependent preparations of nuclear extract.
PI serum, preimmune serum.
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PBX-cooperativity element (PCE). Analysis of the sequence in
region E indicated the presence of four tetrameric sequence
elements that are identical or strongly resemble binding sites
for PBX, MEIS1, and PREP1. These half-sites are designated 1,
2, 3, and 4. To investigate whether PBX heterodimers inter-
acted with region E, gel mobility shift experiments were per-
formed using antibodies against PBX and MEIS1/PREP1.
Incubation of a 32P-labeled oligonucleotide probe containing
region E with nuclear extract from chick embryo hepatocytes
resulted in the formation of two protein-DNA complexes that
were designated a and b in the order of increasing mobility
(Fig. 1B). The pattern of protein binding to region E was sim-
ilar in hepatocytes incubated in the absence and presence of T3
(data not shown) (15). Incubation of hepatocyte nuclear ex-
tracts with antiserum against all isoforms of PBX completely
disrupted the formation of complex a and b, indicating that
these complexes contained PBX or a highly related factor.
Incubation of nuclear extracts with an antibody that reacts
with MEIS1 and PREP1 also completely disrupted the forma-
tion of complex a and complex b. These data indicate that
complex a and complex b contain PBX-MEIS1 and/or PBX-
PREP1 heterodimers. Further evidence that PBX-MEIS1
and/or PBX-PREP1 bound region E in hepatocytes was ob-
tained from competition experiments. An unlabeled oligonu-
cleotide containing the PCE was as effective as an unlabeled
oligonucleotide containing region E in competing for the bind-
ing of complex a and complex b (Fig. 3B).
The ability of region E to bind heterodimers containing PBX-
MEIS1 and PBX-PREP1 was confirmed by gel mobility shift
experiments employing in vitro synthesized transcription fac-
tors. At least 5 isoforms of PBX have been identified that are
derived from three different genes (17, 18, 36). PBX1a, PBX2,
and PBX3a are products of the pbx1, pbx2, and pbx3 genes,
respectively. PBX1b and PBX3b are variants that arise from
alternative processing. As PBX1a and PBX1b are expressed in
hepatic cells (36–38), we investigated whether these proteins
bound region E in the absence or presence of MEIS1 and
PREP1. Incubation of in vitro translated human PBX1a, hu-
man PBX1b, mouse MEIS1, or human PREP1 with the region
E probe resulted in no specific binding activity (Fig. 2). Inclu-
sion of MEIS1 in the binding reactions with PBX1a and PBX1b
stimulated the formation of high affinity protein-DNA com-
plexes containing PBX1a-MEIS1 and PBX1b-MEIS1, respec-
tively. Inclusion of PREP1 in the binding reactions with PBX1a
and PBX1b also stimulated the formation of high affinity het-
erodimeric complexes. Thus, PBX1a and PBX1b bind region E
cooperatively with MEIS1 or PREP1. Cooperative interactions
between PBX1 and MEIS1 and between PBX1 and PREP1
have been reported for other PBX-binding sites (25–28, 32, 33).
The mobilities of the protein-DNA complexes containing
PBX1a-PREP1 and PBX1b-PREP1 were slower than the mo-
bilities of corresponding complexes containing PBX1a-MEIS1
and PBX1b-MEIS1. This was due to the larger size of PREP1
(436 amino acids) relative to MEIS1 (390 amino acids). Inter-
estingly, the mobility of complex a in hepatocyte nuclear ex-
tracts was identical to that of PBX1a-MEIS1 and the mobility
of complex b was identical to that of PBX1b-MEIS1. Assuming
that the sizes of chicken PBX1a, PBX 1b, MEIS1, and PREP1
are similar to their corresponding mammalian homologs, we
propose that complex a and complex b contain PBX1a-MEIS1
and PBX1b-MEIS1, respectively. Complex a may also contain
PBX2-MEIS1 heterodimers, as PBX2 is approximately the
same size of PBX1a, is expressed in liver, and binds DNA
cooperatively with MEIS1 (25, 27, 36). Because expression of
PBX3a and PBX3b in liver is very low compared with that of
PBX1 and PBX2 (36), the former proteins are not likely to be
present in complex a and complex b.
Identification of Sequences in Region E That Bind PBX/
MEIS1 Heterodimers in Nuclear Extracts from Hepatocytes—In
the bovine cyp17 gene, PBX-MEIS1 interacts with a cAMP-
responsive sequence (CRS-1) that consists of tandem 4-bp half-
sites with no spacer between the half-sites (28). Studies with
artificial sequence elements have shown that PBX1-MEIS1 can
also bind tandem half-sites that are separated by 3 or 6 nucle-
otides (49). The sequence in region E contains five possible
binding configurations for PBX-MEIS1 heterodimers (Fig. 3A).
Two of the binding configurations are composed of two half-
sites with no spacer (i.e. sites 1 and 2 and sites 3 and 4),
another two binding configurations are composed of two half-
sites separated by a 3-bp spacer (i.e. sites 1 and 3 and sites 2
and 4), and one binding configuration contains two half-sites
separated by a 7-bp spacer (i.e. sites 1 and 4). To determine
which of these configurations bind complex a and complex b,
competition experiments were performed with oligonucleotide
competitors containing mutations in specific half-sites. Muta-
tion of site 1 (mut E 1), site 2 (mut E 2), or site 3 (mut E 3) had
little or no effect on the binding affinity of complex a and
complex b, whereas mutation of site 4 (mut E 4) decreased the
binding affinity of complex a and complex b (Fig. 3B). These
results suggest that complex a and complex b bind region E in
two or more configurations involving site 4. To delineate fur-
ther the region E binding configurations, competition analyses
were conducted with oligonucleotides containing specific muta-
tions in two of the four half-sites. Mutation of sites 1 and 3 (mut
E 1/3), sites 1 and 4 (mut E 1/4), and sites 2 and 4 (mut E 2/4)
abolished protein binding to region E. Mutation of sites 3 and 4
(mut E 3/4) inhibited but did not abolish the binding of complex
a and complex b to region E. Mutation of sites 1 and 2 and sites
2 and 3 had little or no effect on protein binding activity.
Collectively, these data indicate that complex a and complex b
FIG. 2. PBX1a and PBX1b bind region E cooperatively with
MEIS1 or PREP1. Gel mobility shift assays were performed as de-
scribed under “Experimental Procedures” using 32P-labeled region E
(23767 to 23742 bp) as the probe. In lanes 3–6 and lanes 8–15,
equimolar amounts of in vitro translated PBX1a or PBX1b were incu-
bated in the absence or presence of in vitro translated MEIS1 or PREP1
as indicated. In lane 7, the 32P-labeled probe was incubated with nu-
clear extract from chick embryo hepatocytes (CEH). In lanes 11 and 12,
in vitro synthesized proteins were incubated with antibodies against
PBX or MEIS1/PREP1 prior to the addition of the probe. In lanes 13 and
14, competition analysis was performed with a 100-fold molar excess of
unlabeled competitor DNA. Arrows indicate the binding of complex a
and complex b in chick embryo hepatocytes nuclear extracts. The
bracket indicates the binding of specific complexes formed from in vitro
translated proteins. Asterisks indicate the binding of endogenous com-
plexes in lysates.
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bind region E in the following configurations: half-sites 1 and 2,
half-sites 1 and 4, and half-sites 3 and 4. The binding affinity of
complex a and complex b for half-sites 1 and 2 is lower than
that for half-sites 1 and 4 and half-sites 3 and 4. Competition
analysis with region E mutants indicated that in vitro synthe-
sized PBX1a-MEIS1 and PBX1b-MEIS1 bound region E in a
manner identical to that of complex a and complex b (data not
shown). These data are consistent with the proposal that com-
plex a and complex b contain PBX1a-MEIS1 and PBX1b-
MEIS1, respectively.
Each of the PBX1-MEIS1 binding configurations on region E
overlaps with each other suggesting that complex a and com-
plex b are dimeric rather than tetrameric complexes. To
confirm this supposition, gel mobility shift experiments were
performed with region E probes that contained mutations in
half-sites 1 and 2 (mut E 1/2) or half-sites 2 and 3 (mut E 2/3).
Hepatic nuclear proteins and in vitro synthesized PBX1a,
PBX1b, and MEIS1 bound both of these probes in a pattern
identical to that of the wild-type region E probe (data not
shown). Thus, protein binding to region E represents dimers of
FIG. 3. Complex a and complex b
bind region E in multiple configura-
tions. Gel mobility shift experiments
were performed as described under “Ex-
perimental Procedures” using 32P-labeled
region E (23767 to 23742 bp) as a probe
and nuclear extracts prepared from chick
embryo hepatocytes. Nuclear extracts
were incubated with the region E probe in
the presence of different concentrations of
unlabeled competitor DNAs. Each reac-
tion contained 10 mg of nuclear protein.
DNA and DNA-protein complexes were
resolved on 6% nondenaturing polyacryl-
amide gels. A, possible binding configura-
tions of PBX-MEIS1 on region E. The
position of putative tetrameric half-sites
in region E are indicated by the boxes
above the wild-type sequence for region
E. The half-sites are labeled 1–4. The
sequence of oligonucleotide competitors
containing mutations of one or more half-
sites is also shown. Mut 1 to mut 4 refer to
the number of the half-site that was mu-
tated in each oligonucleotide. The se-
quence of the PCE is shown in Fig. 1A. B,
competition analysis with native and mu-
tant forms of region E. Unlabeled compet-
itor DNAs (2-, 5-, 20-, or 50-fold molar
excess) were mixed with the radiolabeled
probe prior to the addition of nuclear
extract. Complex a and complex b are in-
dicated by arrows. These data are repre-
sentative of four experiments employing
independent preparations of nuclear
extract.
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PBX1a, PBX1b, and MEIS1 and not higher order structures of
these proteins.
Next, we investigated the effects of site-specific mutations of
region E on T3 responsiveness in chick embryo hepatocytes.
Hepatocytes were transiently transfected with reporter con-
structs containing mutations of two of the four half-sites of
region E in the context of p[ME23921/23631]ME2147/
131CAT. A block mutation of region E extending from 23761
to 23744 (mut E block, Fig. 3A) inhibited T3 responsiveness by
58% (Fig. 4). This effect was due to a decrease in promoter
activity in the presence of T3. Site-specific mutations that
abolished protein binding to region E (i.e. mut E 1/3, mut E 1/4,
and mut E 2/4) also inhibited T3 responsiveness, and the extent
of this inhibition was similar to that of the block mutation of
region E. Thus, site-specific mutations that blocked protein
binding to region E also blocked the ability of region E to
stimulate T3 responsiveness. Site-specific mutations that had
no effect (i.e. mut E 1/2 and mut E 2/3) or partially inhibited
(i.e. mut E 3/4) protein binding to region E conferred a higher
level of T3 responsiveness than mutations that abolished pro-
tein binding to region E (i.e. mut E block, mut E 1/3, mut E 1/4,
and mut E 2/4). Mut E 2/3 conferred the highest level of T3
responsiveness of all of the mutations examined. These data
indicate that all three PBX-MEIS1 binding configurations on
region E are capable of enhancing T3 responsiveness directed
by the upstream region of the malic enzyme gene and that
binding to half-sites 1 and 4 results in the greatest stimulation
of T3 responsiveness. Interestingly, the latter configuration
perfectly matches the consensus binding sequence for PBX1-
MEIS1 heterodimers (i.e. TGATTGAC) (26, 27) except that the
tetrameric half-sites are separated by a 7-bp spacer. This is the
first description of a native PBX1-MEIS1-binding sequence
with this arrangement of half-sites.
Region E Alone Can Enhance T3 Regulation Directed by a
T3RE—PBX-MEIS1 bound to region E (23762/23748 bp) may
enhance T3 regulation of malic enzyme transcription by inter-
acting with TR-RXR heterodimers bound to the T3RU (23878/
23769 bp). Alternatively, PBX-MEIS1 may enhance T3 respon-
siveness by interacting with other TR accessory factors bound
to sequences flanking the T3RU. For example, PBX-MEIS1
may interact with C/EBPa bound to region F (23703/23686
bp). To assess the role of these possible mechanisms of PBX-
MEIS1 action, transient transfection experiments were con-
ducted to determine whether region E alone could enhance T3
regulation of transcription conferred by a T3RE. Within the
malic enzyme T3RU is a strongly active T3RE designated as
T3RE-2 (23878/23863 bp). When hepatocytes were transfected
with a reporter plasmid containing T3RE-2 linked to the min-
imal promoter of the malic enzyme gene (p[T3RE-2]ME2147/
131CAT), T3 stimulated a 10-fold increase in promoter activity
FIG. 4. Stimulation of T3 responsiveness by region E is correlated with complex a and complex b binding activity. p[ME23921/
23631]ME2147/131CAT or constructs containing mutations of region E in the context of p[ME23921/23631]ME2147/131CAT were transiently
transfected into chick embryo hepatocytes as described under “Experimental Procedures.” Transfections also contained CMV-b-galactosidase as a
control for transfection efficiency. After the transfection, cells were treated with or without T3 for 48 h. Cells were then harvested, extracts
prepared, and CAT and b-galactosidase assays performed. Left, the constructs used in these experiments. Numbers indicate the 59 or 39 boundaries
of malic enzyme DNA in nucleotides relative to the start site for transcription. The mutated sequences in region E are shown in Fig. 3A. Right,
CAT activity was expressed relative to b-galactosidase activity to correct for differences in transfection efficiency. CAT activity in cells transfected
with pME2147/131CAT and incubated without T3 was set at 1, and the other activities were adjusted proportionately. The -fold stimulation by
T3 was calculated by dividing CAT activity in hepatocytes treated with T3 (1T3) by that for hepatocytes not treated with T3 (2T3). The -fold
responses were calculated for individual experiments and then averaged. The results are the means 6 S.E. of 5 experiments. *, the -fold stimulation
by T3 was significantly higher than that of cells transfected with p[ME23921/23631] ME2147/131CAT containing mut E block (p , 0.05).
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(Fig. 5). When a DNA fragment containing region E (23767/
23742 bp) was inserted downstream of T3RE-2 in p[T3RE-
2]ME2147/131CAT, the T3-induced stimulation of promoter
activity was increased to 47-fold. The increase in T3 respon-
siveness caused by region E was due to an increase in promoter
activity in the presence of T3. Insertion of DNA fragment
containing mut E block downstream of T3RE-2 in p[T3RE-
2]ME2147/131CAT had no effect on T3 responsiveness, indi-
cating that the increase in T3 responsiveness caused by region
E was not due to changes in the spacing between T3RE-2 and
the minimal malic enzyme promoter. Region E also enhanced
T3 responsiveness when it was ligated downstream to the malic
enzyme T3RU in p[ME23921/23768]ME2147/131CAT (data
not shown). These data indicate that the stimulation of T3-
induced malic enzyme transcription caused by region E is me-
diated, at least in part, by interactions between PBX-MEIS1
and TR-RXR.
PBX1 Physically Interacts with TR—Previous studies have
demonstrated that PBX-MEIS1 heterodimers function as cofac-
tors for other transcription factors (50). For example, PBX1-
MEIS1 bound to a PCE strongly augments transcriptional
activation by MyoD or myogenin containing complexes bound
to an adjacent E box motif. This effect of PBX1-MEIS1 is
mediated, in part, by direct interactions between the PBX1
homeodomain and a highly conserved tryptophan motif flank-
ing the basic helix-loop-helix domain of MyoD and myogenin.
These findings coupled with the close proximity of region E to
the T3RU led us to hypothesize that PBX1-MEIS1 enhanced T3
responsiveness of malic enzyme transcription by directly inter-
acting with TR-RXR. To investigate this hypothesis, we deter-
mined whether PBX1 or MEIS1 physically interacted with TR
and RXR using a pull-down assay. In our initial experiments,
we investigated the ability of in vitro synthesized TRa and
RXRa to bind a bacterially expressed fusion protein containing
glutathione S-transferase (GST) linked to PBX1a. 35S-Labeled
TRa bound to GST-PBX1a, and the presence of T3 enhanced
this interaction (Fig. 6B). 35S-Labeled TRa also interacted with
GST-PBX1b in a T3-regulated manner (Fig. 6C). Inclusion of
unlabeled RXRa in the binding reaction had no effect on the
interaction of 35S-labeled TRa with GST-PBX1a and GST-
PBX1b (data not shown). No interaction was observed between
35S-labeled TRa and GST. In contrast to the results for TRa,
little or no interaction was observed between 35S-labeled RXRa
and GST-PBX1a (Fig. 6B) and between 35S-labeled RXRa and
GST-PBX1b (Fig. 6C). The lack of interaction between RXRa
and PBX1 proteins was confirmed by pull-down experiments
employing GST-RXRa as the bait and 35S-labeled PBX1a and
PBX1b synthesized in vitro (data not shown). These data indi-
cate that PBX1a and PBX1b selectively interact with TR of the
TR-RXR heterodimeric complex.
Pull-down assays were also carried out using GST-TRa as
the bait protein. Consistent with results of experiments em-
ploying GST-PBX1a and GST-PBX1b as bait proteins, 35S-
labeled PBX1a and PBX1b strongly interacted with GST-TRa
(Fig. 7). In contrast, a very weak interaction was observed
between 35S-labeled MEIS1 and GST-TRa in the absence or
presence of unlabeled PBX1a. These data further demonstrate
that interactions between PBX1 proteins and TRa are specific.
In contrast to results of experiments analyzing interactions
between GST-PBX1 proteins and 35S-labeled TRa, interactions
between GST-TRa and 35S-labeled PBX1 proteins were not
affected by the presence of T3. The latter observation suggests
that appending GST to the N terminus of TRa blocks ligand-
induced conformational changes that facilitate interactions be-
tween TRa and PBX1 proteins.
To map the motifs in TRa that interact with PBX1a, pull-
down experiments were conducted using various truncations of
TRa labeled with 35S in vitro. Deletion of the first 20 amino
acids from the N terminus of TRa had little or no effect on the
binding of TRa to GST-PBX1a (Fig. 8). Further deletion to
amino acid 51 decreased the binding of TRa to GST-PBX1a.
When deletion of the N terminus of TRa was extended to amino
acid 120, binding of TRa to GST-PBX1a was abolished. To
analyze further the interaction between TRa and PBX1a, TRa
polypeptides containing amino acids 1–157, amino acids 1–118,
and amino acids 51–157 were tested for their ability to interact
with GST-PBX1a. A strong interaction was observed between
GST-PBX1a and a TRa polypeptide containing amino acids
1–157. Markedly weaker but detectable interactions were ob-
served between GST-PBX1a and TRa polypeptides containing
amino acids 1–118 and amino acids 51–157. GST-PBX1b bound
to TRa truncations in a manner similar to that of GST-PBX1a
(data not shown). Collectively, these data suggest that a TRa
region containing the DNA binding domain plus flanking se-
quences (amino acids 21–157) is required for optimal binding to
PBX1a and PBX1b. Interestingly, interactions between GST-
PBX1 fusion proteins and TRa truncations lacking the ligand
binding domain were not enhanced by the presence of T3. This
observation is consistent with the scenario that T3 binding to
the ligand binding domain of TRa causes a conformational
FIG. 5. Region E alone can enhance T3 regulation directed by a T3RE. Oligonucleotides containing region E (23767 to 23742 bp) or a
block mutation of region E (mut E block) were inserted downstream of malic enzyme T3RE-2 in p[T3RE-2]ME2147/131CAT. Hepatocytes were
transiently transfected with these constructs and treated with or without T3 as described in the legend to Fig. 4 and under “Experimental
Procedures.” Left, constructs used in these experiments. The sequence for region E and mut E block are shown in Fig. 3A. Right, CAT activity in
cells transfected with p[T3RE-2]ME2147/131CAT and treated without T3 was set at 1, and the other activities were adjusted proportionately. The
-fold stimulation by T3 was calculated as described in the legend in Fig. 4. The results are the means 6 S.E. of 5 experiments. *, the -fold
stimulation by T3 for p[T3RE-21Region E]ME2147/131CAT was significantly higher than that of any other construct (p , 0.05).
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change that enhances the ability of the N-terminal region of
TRa to interact with PBX1a and PBX1b.
Previous studies have shown that heterodimeric interactions
between PBX1 and MEIS1 are mediated by a PBX1 region
containing a 3,4-isoleucine heptad repeat (26). This region is
designated as the MEIS cooperativity domain (MCD) and ex-
tends from amino acids 22 to 75 (Fig. 6A). To investigate
whether TRa interacted with a PBX1 region that was separate
from the MCD, we determined the ability of N-terminal trun-
cations of PBX1a to interact with GST-TRa. Deletion of the
first 79 or 118 amino acids of PBX1a had no effect on the
binding of PBX1a to GST-TRa (data not shown). These data
indicate that TRa interacts with a PBX1 region that is distinct
from that mediating heterodimeric interactions with MEIS1.
DISCUSSION
Protein complexes containing PBX and MEIS1/PREP1 play a
critical role in embryonic development in both invertebrates
and vertebrates (29–31). Although less is known about the
functions of PBX-MEIS1/PREP1 in adult tissues, data from
recent studies suggest that these complexes are involved
in controlling endocrine function. For example, PBX-MEIS1
complexes mediate the stimulatory effects of cAMP on tran-
scription of 17a-hydroxylase cytochrome P450, a steroid hy-
droxylase involved in the production of steroid hormones from
cholesterol (28, 37, 51). Other studies have shown that PBX-
PREP1 complexes are involved in mediating the pancreatic-
specific expression of the genes for somatostatin (32) and glu-
cagon (33). Still other studies have demonstrated that
interactions between PBX complexes and the glucocorticoid
receptor mediate the inhibitory effect of glucocorticoids on pro-
lactin transcription in non-pituitary cell lines (38). In the pres-
ent study, we show that PBX-MEIS1 complexes interact with
TR-RXR complexes to enhance T3 regulation of malic enzyme
transcription in avian hepatocytes. These studies are the first
to establish a role for PBX-MEIS1 in the control of thyroid
hormone action.
Data from transfection (Figs. 4 and 5) and protein binding
assays (Figs. 6 and 7) suggest that stimulation of T3-induced
malic enzyme transcription by region E is mediated by direct
interactions between PBX-MEIS1 and TR-RXR. Due to the
close proximity of region E to the T3RU, PBX-MEIS1 may bind
the malic enzyme gene as a tetrameric complex with TR-RXR.
In support of this possibility, peptide sequences mediating the
interaction between PBX1a/b and TRa are distinct from those
mediating interactions between PBX1a/b and MEIS1 (data not
shown) and between TRa and RXRa (Fig. 8). Furthermore, in
gel mobility shift assays, in vitro synthesized TRa, RXRa,
PBX1a/b, and MEIS1 form a complex containing all four pro-
teins on an oligonucleotide probe consisting of T3RE-2 linked to
region E (data not shown). Because the formation of this tet-
rameric complex is not associated with any changes in the total
binding of TRa-RXRa and PBX1a/b-MEIS1 to the probe, the
mechanism by which region E modulates T3 responsiveness
does not appear to involve alterations in DNA binding. Previ-
ous studies have shown that the stimulatory effects of T3 on
transcription are mediated by the recruitment of coactivator
proteins to the TR (10, 52). Coactivators of TR may regulate
transcription by directly interacting with the basal transcrip-
tional machinery, by modulating interactions between TR and
the basal transcriptional machinery, and by modifying chroma-
tin structure. Complex formation between TR-RXR and PBX-
MEIS1 may augment T3-induced malic enzyme transcription
by facilitating the recruitment of coactivators to the malic
enzyme promoter.
A role for PBX-MEIS1 complexes in modulating the T3 re-
sponsiveness of the malic enzyme gene may be conserved in
humans. Sequence comparison analysis of the human malic
enzyme gene indicates the presence of a putative PCE at 2140/
2124 bp. This PCE is located immediately upstream of a pre-
viously described T3RE at 2105/287 bp (53) and is composed of
consecutive tetrameric half-sites (TGAT and TGAC) separated
by a 9-bp spacer. Gonza´lez-Mancho´n et al. (53) have shown that
the region containing the putative PCE enhances T3 respon-
siveness conferred by the T3RE at 2105/287.
A role for accessory DNA binding factors in modulating T3
responsiveness has been described for other genes. For exam-
ple, the T3-induced stimulation of the phosphoenolpyruvate
carboxykinase promoter in hepatoma cells is mediated by a
T3RE and a sequence that binds the liver-enriched factors,
C/EBPa and C/EBPb (54). In primary hepatocyte cultures, T3
stimulation of the S14 gene requires the presence of T3REs
located between 22700 and 22500 bp and a nuclear factor
Y-binding site near the transcription start site (55). Increased
FIG. 6. TRa interacts with PBX1a and PBX1b in a T3-regulated
manner. A, schematic representation of PBX1a and PBX1b. The MEIS
cooperativity domain (MCD) and homeodomain (HD) region are indi-
cated. B, TRa interacts with GST-PBX1a. Bacterially produced GST or
GST-PBX1a immobilized on glutathione-Sepharose beads was incu-
bated with in vitro translated and 35S-labeled TRa or RXRa as de-
scribed under “Experimental Procedures.” Incubations were performed
in the absence and presence of 1 mM T3 or 1 mM 9-cis-retinoic acid (9-cis
RA) as indicated. After the matrix was extensively washed, labeled
proteins retained on the beads were eluted, resolved by SDS-PAGE, and
visualized by storage phosphor autoradiography together with 10% of
the total radiolabeled receptor input used in each binding reaction. C,
incubations were performed as described in B except that GST-PBX1b
was used as the bait protein. These data are representative of four
experiments.
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T3 responsiveness of the rat growth hormone promoter in pi-
tuitary cells relative to non-pituitary cells is mediated by a
synergistic interaction between TR and the pituitary-specific
DNA-binding protein, Pit-1 (also referred to as GHF-1) (56).
Physical interactions between Pit-1 and TR enhance the bind-
ing of TR to the rat growth hormone promoter (57). In cardiac
muscle cells, myocyte-specific enhancer factor 2 potentiates the
ability of TR to stimulate a-cardiac myosin heavy chain tran-
scription in the presence of T3 (58). Protein binding assays
indicate that myocyte-specific enhancer factor 2 and TR specif-
ically bind each other. Collectively, these findings and the
results of the present study indicate that a wide variety of
transcription factors can interact with TR on promoters of
T3-responsive genes. Such factors expand the dynamic range
of T3 responsiveness and constitute an important mechanism
by which T3 regulates transcription in a tissue- or cell type-
specific manner.
Complexes containing PBX-MEIS1/PREP1 have been shown
to function as accessory proteins for other transcription factors
besides TR. For example, on the urokinase plasminogen acti-
vator promoter, PBX-PREP1 binds a cooperation mediating
element that is positioned between an activator protein-1
(AP-1) site and a combined PEA3/AP-1 site (25, 59). Binding of
PBX-PREP1 to the cooperation mediating element is required
for synergistic activation of urokinase plasminogen activator
transcription by the AP-1 and PEA3/AP-1 sites. The elastase I
promoter contains a PBX-binding site that consists of part of an
enhancer element conferring cell type-specific regulation of
transcription (34, 60). In pancreatic acinar cells, this PBX-
binding site potentiates the transcriptional activity of an adja-
cent element that binds the pancreatic acinar cell-specific
factor, PTF-1. The somatostatin promoter contains adjacent
binding sites for PBX-PREP1 and the pancreatic cell-specific
factor, PDX1 (32). PBX-PREP1 alone is devoid of transcrip-
tional activity but interacts with PDX1 to stimulate a 10-fold
increase in somatostatin promoter activity. This functional in-
teraction between PBX-PREP1 and PDX1 is not mediated by
alterations in the binding of PBX-PREP1 and PDX1 to the
somatostatin promoter. E2a-MyoD heterodimers in muscle cell
nuclear extracts bind to E box motifs that are flanked at their
59 end by a PCE (50). In transfection assays, the binding of
PBX-MEIS1 to the PCE enhances transcriptional activation by
FIG. 7. TRa strongly interacts with PBX1a and PBX1b but not MEIS1. GST or GST-TRa immobilized on glutathione-Sepharose beads was
incubated with in vitro translated and 35S-labeled PBX1a, PBX1b, or MEIS1 in the absence and presence of T3. An equimolar amount of unlabeled
MEIS1 was included in some incubations containing 35S-labeled PBX1a and PBX1b. After the matrix was extensively washed, labeled proteins
retained on the beads were eluted, resolved by SDS-PAGE, and visualized by storage phosphor autoradiography together with 10% of the total
radiolabeled protein input used in each binding reaction. Additional experimental details are described under “Experimental Procedures.”
FIG. 8. A TRa region containing
amino acids 21–157 is required for op-
timal binding to PBX1a. A, the sche-
matic representation of TRa. The DNA
binding domain (DBD) and the ligand bind-
ing domain (LBD) are indicated. Embed-
ded within the LBD of TRa is a heptad
repeat region involved in dimerization. A
ligand-induced change in the conformation
of the LBD is responsible for providing an
interface for interaction with coactivator
proteins. B, wild-type and truncated forms
of TRa labeled with 35S by in vitro transla-
tion were incubated with GST or GST-
PBX1a bound to glutathione-Sepharose
beads. After the matrix was extensively
washed, labeled proteins retained on the
beads were eluted, resolved by SDS-PAGE,
and visualized by storage phosphor autora-
diography together with 10% of the total
radiolabeled protein input used in each
binding reaction.
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E2a-MyoD bound to the adjacent E box motif. In contrast to the
interaction between PBX-PREP1 and PDX1 on the somatosta-
tin promoter and the interaction between PBX-MEIS1 and
TR-RXR on the malic enzyme promoter, the interaction be-
tween PBX-MEIS1 and E2a-MyoD on the PCE/E-box element
is mediated, in part, by alterations in protein binding to DNA.
These studies indicate that PBX-MEIS1/PREP1 complexes
functionally interact with a wide variety transcription factors
and that the mechanisms mediating these interactions vary
depending on the nature of the proteins that interact with
PBX-MEIS1/PREP1.
The results of the present study are the first to establish a
role for PBX and MEIS1 in the control of gene transcription in
hepatocytes. PBX1-MEIS complexes may regulate the tran-
scription of other genes in liver besides malic enzyme. For
example, the AC element of the phosphoenolpyruvate car-
boxykinase promoter contains a sequence (2255 to 2248 bp)
that perfectly matches the consensus PCE, TGATTGAC. Mu-
tation of the AC element abrogates the effects of cAMP and
insulin on phosphoenolpyruvate carboxykinase transcription
in H4IIe hepatoma cells (61). There are no reports addressing
whether PBX-MEIS1 binds to the AC element. Additional ex-
perimentation will be needed to determine whether PBX-
MEIS1 complexes play a broader role in the regulation of genes
involved in carbohydrate and lipid metabolism in liver.
Several coactivators of TR have been identified that enhance
T3-dependent transcriptional activation by physically interact-
ing with the ligand binding domain (LBD) of TR. Examples of
such proteins include CREB-binding protein (62) and steroid
receptor coactivator 1 (63). T3-dependent transcriptional acti-
vation is also controlled by nuclear proteins that physically
interact with TR regions distinct from the LBD. For example,
the general transcription factor, TFIIB, facilitates T3-depend-
ent transcriptional activation by interacting with a 10-amino
acid sequence in the A/B region of TRa (64). Myocyte-specific
enhancer factor 2 and the hematopoietic basic ZIP protein
p45/NF-E2 enhance T3-dependent transcriptional activation
by interacting with the DNA binding domain of TR (58, 65).
Results from the present study demonstrating that PBX1a/b
interacts with sequences in the A/B region and DNA binding
domain of TRa provide further support for a role of TR regions
distinct from the LBD in modulating T3-dependent transcrip-
tional activation.
Results from DNA binding analyses (Fig. 3) indicate that
region E contains a novel PCE that binds PBX-MEIS1 het-
erodimeric complexes in three different configurations. One
configuration is composed of tandem half-sites separated by a
7-bp spacer (i.e. half-sites 1 and 4) and the other two configu-
rations are composed of tandem half-sites with no spacer se-
quence (i.e. half-sites 1 and 2 and half-sites 3 and 4). Results
from transfection experiments suggest that all three binding
configurations contribute to the stimulation of T3 responsive-
ness by region E with binding to half-sites 1 and 4 making the
greatest contribution. Interestingly, site-specific mutations of
region E that restricted PBX-MEIS1 binding to half-sites 1 and
4 (mut E 2/3) or half-sites 3 and 4 (mut E 1/2) had no effect on
the DNA binding affinity yet conferred a smaller increase in T3
responsiveness than wild-type region E. This observation sug-
gests that sequences flanking the half-sites and/or the distance
between the half-sites can modulate the functional activity of
PBX-MEIS1 complexes without altering their ability to bind
DNA.
We previously reported that region E was one of four cis-
acting elements mediating differences in T3 regulation of malic
enzyme transcription between chick embryo hepatocytes and
chick embryo fibroblasts (15). This conclusion was based on the
finding that mutation of region E markedly inhibited T3 regu-
lation of malic enzyme transcription in chick embryo hepato-
cytes but had no effect on T3 regulation in chick embryo fibro-
blasts. Cell type-dependent differences in region E activity are
probably not due to alterations in expression of PBX and
MEIS1, as these proteins are expressed in a wide variety of
tissues (17, 18, 36, 40). This supposition is supported by data
from gel mobility shift assays demonstrating that the pattern
and extent of protein binding to region E in chick embryo
fibroblasts is similar to that observed in chick embryo hepato-
cytes (15). We postulate that the difference in region E activity
between chick embryo hepatocytes and chick embryo fibro-
blasts is mediated by a post-translational mechanism. One
possibility is that PBX-MEIS1 interacts with an activator or
inhibitor whose activity varies in different cell types. In sup-
port of this possibility, Abramovich et al. (66) have recently
identified a novel PBX-interacting protein that inhibits the
ability of PBX complexes to bind DNA and activate transcrip-
tion. Further studies are needed to determine the role of this
protein in mediating differences in T3 responsiveness between
chick embryo hepatocytes and chick embryo fibroblasts.
In summary, the present study establishes a role for PBX-
MEIS1 complexes in conferring optimal T3 regulation of
malic enzyme transcription in liver. Stimulation of T3-
induced transcription by PBX-MEIS1 may by mediated by
physical interactions between PBX and TR. The observation
that PBX-MEIS1 heterodimers functionally and physically
interact with TR provides further support for the proposal
that PBX-MEIS1 heterodimers serve as accessory transcrip-
tion factors in the developmental and hormonal regulation of
gene expression (50).
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